Sliwkowski; Mark X.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Sliwkowski; Mark X..The latest application filed is for "anti-her2 antibodies and immunoconjugates".
Company Profile
3.35.69
- Sliwkowski; Mark X. - San Carlos CA
- Sliwkowski; Mark X. - South San Francisco CA
- Sliwkowski; Mark X - San Carlos CA
Patent Activity
| Patent | Date |
|---|---|
| Anti-HER2 Antibodies and Immunoconjugates App 20200255539 - Kind Code | 2020-08-13 |
| Pyrrolobenzodiazepine antibody drug conjugates and methods of use Grant 10,639,373 - Dragovich , et al. | 2020-05-05 |
| Pyrrolobenzodiazepine antibody drug conjugates and methods of use Grant 10,632,196 - Dragovich , et al. | 2020-04-28 |
| Immunoconjugates Comprising Anti-HER2 Antibodies and Pyrrolobenzodiazepines App 20200085840 - Chen; Xiaocheng ; et al. | 2020-03-19 |
| Anti-HER2 antibodies and immunoconjugates Grant 10,556,966 - Chen , et al. Feb | 2020-02-11 |
| Combinations Of An Anti-her2 Antibody-drug Conjugate And Chemotherapeutic Agents, And Methods Of Use App 20190374547 - Sliwkowski; Mark X. ; et al. | 2019-12-12 |
| Anti-HER2 Antibodies and Immunoconjugates App 20190177429 - Chen; Xiaocheng ; et al. | 2019-06-13 |
| Immunoconjugates comprising anti-HER2 antibodies and pyrrolobenzodiazepines Grant 10,314,846 - Chen , et al. | 2019-06-11 |
| Anti-HER2 antibodies and immunoconjugates Grant 10,179,820 - Chen , et al. Ja | 2019-01-15 |
| Pyrrolobenzodiazepine Antibody Drug Conjugates And Methods Of Use App 20180326062 - Dragovich; Peter ; et al. | 2018-11-15 |
| Pyrrolobenzodiazepine antibody drug conjugates and methods of use Grant 10,058,613 - Dragovich , et al. August 28, 2 | 2018-08-28 |
| Pyrrolobenzodiazepine Antibody Drug Conjugates And Methods Of Use App 20180185486 - Dragovich; Peter ; et al. | 2018-07-05 |
| Isoform specific anti-HER4 antibodies Grant 9,963,517 - Sliwkowski , et al. May 8, 2 | 2018-05-08 |
| Immunoconjugates Comprising Anti-her2 Antibodies And Pyrrolobenzodiazepines App 20170274092 - Chen; Xiaocheng ; et al. | 2017-09-28 |
| Anti-her2 Antibodies And Immunoconjugates App 20170174782 - Chen; Xiaocheng ; et al. | 2017-06-22 |
| Combinations Of Anti-her2 Antibody-drug Conjugate And Chemotherapeutic Agents, And Methods Of Use App 20170136026 - Sliwkowski; Mark X. ; et al. | 2017-05-18 |
| Pyrrolobenzodiazepine Antibody Drug Conjugates And Methods Of Use App 20170095570 - Dragovich; Peter ; et al. | 2017-04-06 |
| Anti-HER2 antibodies and immunoconjugates Grant 9,518,118 - Chen , et al. December 13, 2 | 2016-12-13 |
| Anti-HER antibodies Grant 9,327,035 - Fuh , et al. May 3, 2 | 2016-05-03 |
| Anti-her2 Antibodies And Immunoconjugates App 20160096893 - Chen; Xiaocheng ; et al. | 2016-04-07 |
| Isoform Specific Anti-her4 Antibodies App 20160075798 - Sliwkowski; Mark X. ; et al. | 2016-03-17 |
| Combination Therapy Of Her Expressing Tumors App 20150086545 - Sliwkowski; Mark X ; et al. | 2015-03-26 |
| Combinations Of A Mek Inhibitor Compound With An Her3/egfr Inhibitor Compound And Methods Of Use App 20140271634 - Sliwkowski; Mark X. ; et al. | 2014-09-18 |
| Anti-her Antibodies App 20140193414 - Fuh; Germaine ; et al. | 2014-07-10 |
| Combinations Of An Anti-her2 Antibody-drug Conjugate And Chemotherapeutic Agents, And Methods Of Use App 20140140993 - Ross; Leanne Berry ; et al. | 2014-05-22 |
| Antibody-drug Conjugates And Methods App 20140128580 - Ebens, JR.; Allen J. ; et al. | 2014-05-08 |
| Combinations of an anti-HER2 antibody-drug conjugate and chemotherapeutic agents, and methods of use Grant 8,663,643 - Berry , et al. March 4, 2 | 2014-03-04 |
| Anti-her Antibodies App 20140056899 - Fuh; Germaine ; et al. | 2014-02-27 |
| Antibody-drug conjugates and methods Grant 8,652,479 - Ebens, Jr. , et al. February 18, 2 | 2014-02-18 |
| Multispecific anti-HER antibodies Grant 8,597,652 - Fuh , et al. December 3, 2 | 2013-12-03 |
| Combination Therapy Of Her Expressing Tumors App 20120251530 - Sliwkowski; Mark X ; et al. | 2012-10-04 |
| Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20120148610 - Doronina; Svetlana O. ; et al. | 2012-06-14 |
| Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20120148608 - Doronina; Svetlana O. ; et al. | 2012-06-14 |
| Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20120141508 - Doronina; Svetlana O. ; et al. | 2012-06-07 |
| Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20120141510 - Doronina; Svetlana O. ; et al. | 2012-06-07 |
| Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20120141509 - Doronina; Svetlana O. ; et al. | 2012-06-07 |
| Bispecific Anti-her Antibodies App 20120121596 - Fuh; Germaine ; et al. | 2012-05-17 |
| Combinations Of An Anti-her2 Antibody-drug Conjugate And Chemotherapeutic Agents, And Methods Of Use App 20120107302 - Berry; Leanne ; et al. | 2012-05-03 |
| Combination therapy of her expressing tumors Grant 8,163,287 - Sliwkowski , et al. April 24, 2 | 2012-04-24 |
| Antibody-drug conjugates and methods Grant 8,142,784 - Ebens, Jr. , et al. March 27, 2 | 2012-03-27 |
| Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20120034246 - DORONINA; SVETLANA O. ; et al. | 2012-02-09 |
| Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20120034247 - Doronina; Svetlana O. ; et al. | 2012-02-09 |
| Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20120027783 - DORONINA; SVETLANA O. ; et al. | 2012-02-02 |
| Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20120027784 - Doronina; Svetlana O. ; et al. | 2012-02-02 |
| Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20120003248 - Doronina; Svetlana O. ; et al. | 2012-01-05 |
| Monomethylvaline compounds capable of conjugation to ligands Grant 7,994,135 - Doronina , et al. August 9, 2 | 2011-08-09 |
| Monomethylvaline compounds capable of conjugation to ligands Grant 7,964,567 - Doronina , et al. June 21, 2 | 2011-06-21 |
| Monomethylvaline compounds capable of conjugation to ligands Grant 7,964,566 - Doronina , et al. June 21, 2 | 2011-06-21 |
| Methods for Identifying Tumors That are Responsive to Treatement With Anti-ErbB2 Antibodies App 20110117096 - BOSSENMAIER; BIRGIT ; et al. | 2011-05-19 |
| Tissue analysis and kits therefor Grant 7,919,254 - Cohen , et al. April 5, 2 | 2011-04-05 |
| Anti-her Antibodies App 20100255010 - Fuh; Germaine ; et al. | 2010-10-07 |
| Antibodies to human ErbB4 App 20100190964 - Gerritsen; Mary E. ; et al. | 2010-07-29 |
| Monomethylvaline compounds capable of conjugation to ligands Grant 7,745,394 - Doronina , et al. June 29, 2 | 2010-06-29 |
| Tissue Analysis And Kits Therefor App 20100120053 - COHEN; ROBERT L. ; et al. | 2010-05-13 |
| ErbB4 antagonists Grant 7,704,498 - Gerritsen , et al. April 27, 2 | 2010-04-27 |
| Methods for tissue analysis Grant 7,674,589 - Cohen , et al. March 9, 2 | 2010-03-09 |
| Antibody-drug Conjugates And Methods App 20090202536 - Ebens, JR.; Allen J. ; et al. | 2009-08-13 |
| Methods For Tissue Analysis App 20090155803 - Cohen; Robert L. ; et al. | 2009-06-18 |
| Therapy Of Non-malignant Diseases Or Disorders With Anti-erbb2 Antibodies App 20090148402 - Brunetta; Paul G. ; et al. | 2009-06-11 |
| TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES App 20090087432 - Sliwkowski; Mark X. | 2009-04-02 |
| ErbB4 antagonists App 20090068205 - Gerritsen; Mary E. ; et al. | 2009-03-12 |
| Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20090047296 - Doronina; Svetlana O. ; et al. | 2009-02-19 |
| Methods for tissue analysis Grant 7,468,252 - Cohen , et al. December 23, 2 | 2008-12-23 |
| Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20080248051 - Doronina; Svetlana O. ; et al. | 2008-10-09 |
| Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20080248053 - Doronina; Svetlana O. ; et al. | 2008-10-09 |
| Monomethylvaline Compounds Capable Of Conjugation To Ligands App 20080226657 - Doronina; Svetlana O. ; et al. | 2008-09-18 |
| Antibody-drug Conjugates And Methods App 20080171040 - Ebens,; Allen J. ; et al. | 2008-07-17 |
| Tissue analysis and kits therefor Grant 7,344,840 - Cohen , et al. March 18, 2 | 2008-03-18 |
| Tissue Analysis and Kits Therefor App 20080050748 - Cohen; Robert L. ; et al. | 2008-02-28 |
| Antibodies to human ErbB4 Grant 7,332,579 - Gerritsen , et al. February 19, 2 | 2008-02-19 |
| Treatment With Anti-erbb2 Antibodies App 20070269429 - Kelsey; Stephen M. ; et al. | 2007-11-22 |
| Treatment With Anti-erbb2 Antibodies App 20070184055 - SLIWKOWSKI; MARK X. | 2007-08-09 |
| ErbB4 antagonists App 20070092513 - Gerritsen; Mary E. ; et al. | 2007-04-26 |
| Combination therapy of her expressing tumors App 20070020261 - Sliwkowski; Mark X. ; et al. | 2007-01-25 |
| Use of heregulin as a growth factor Grant 7,153,828 - Sliwkowski , et al. December 26, 2 | 2006-12-26 |
| Tissue analysis and kits therefor Grant 7,129,051 - Cohen , et al. October 31, 2 | 2006-10-31 |
| Methods for identifying tumors responsive to treatment with HER dimerization inhibitors (HDIs) App 20060204505 - Sliwkowski; Mark X. ; et al. | 2006-09-14 |
| Tissue analysis and kits therefor App 20060183150 - Cohen; Robert L. ; et al. | 2006-08-17 |
| Heregulin variants App 20060183194 - Ballinger; Marcus D. ; et al. | 2006-08-17 |
| Heregulin variants Grant 7,063,961 - Ballinger , et al. June 20, 2 | 2006-06-20 |
| Treating prostate cancer with anti-ErbB2 antibodies Grant 7,041,292 - Sliwkowski May 9, 2 | 2006-05-09 |
| ErbB4 antagonists App 20060093603 - Gerritsen; Mary E. ; et al. | 2006-05-04 |
| Treating prostate cancer with anti-ErbB2 antibodies App 20060083739 - Sliwkowski; Mark X. | 2006-04-20 |
| Antibody-drug conjugates and methods App 20050276812 - Ebens, Allen J. JR. ; et al. | 2005-12-15 |
| Monomethylvaline compounds capable of conjugation to ligands App 20050238649 - Doronina, Svetlana O. ; et al. | 2005-10-27 |
| Tissue analysis and kits therefor Grant 6,905,830 - Cohen , et al. June 14, 2 | 2005-06-14 |
| Tissue analysis and kits therefor App 20050100944 - Cohen, Robert L. ; et al. | 2005-05-12 |
| Therapy of non-malignant diseases or disorders with anti-ErbB2 antibodies App 20040258685 - Brunetta, Paul G. ; et al. | 2004-12-23 |
| Methods for identifying tumors that are responsive to treatment with anti-ErbB2 antibodies App 20040106161 - Bossenmaier, Birgit ; et al. | 2004-06-03 |
| Erbb4 antagonists App 20040052786 - Gerritsen, Mary E ; et al. | 2004-03-18 |
| Treatment with anti-ErbB2 antibodies App 20040013667 - Kelsey, Stephen M. ; et al. | 2004-01-22 |
| Use of heregulin as a growth factor App 20030199429 - Sliwkowski, Mark X. ; et al. | 2003-10-23 |
| Tissue analysis and kits therefor App 20030152987 - Cohen, Robert L. ; et al. | 2003-08-14 |
| Heregulin variants App 20030129688 - Ballinger, Marcus D. ; et al. | 2003-07-10 |
| Tissue analysis and kits therefor Grant 6,573,043 - Cohen , et al. June 3, 2 | 2003-06-03 |
| Treatment with anti-ErbB2 antibodies App 20030086924 - Sliwkowski, Mark X. | 2003-05-08 |
| ErbB4 antagonists App 20020119148 - Gerritsen, Mary E. ; et al. | 2002-08-29 |
| Heregulin variants Grant 6,387,638 - Ballinger , et al. May 14, 2 | 2002-05-14 |
| Use of heregulin as a growth factor App 20020042087 - Sliwkowski, Mark X. ; et al. | 2002-04-11 |
| Use of heregulin as a growth factor App 20010023241 - Sliwkowski, Mark X. ; et al. | 2001-09-20 |
| Heregulin variants Grant 6,136,558 - Ballinger , et al. October 24, 2 | 2000-10-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 